Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Ruiyun Zhang is a leading urologic surgeon and researcher whose work centers on optimizing surgical outcomes for patients with muscle-invasive bladder cancer. Her primary research focus is the refinement of robot-assisted radical cystectomy (RARC), particularly comparing urinary diversion techniques. Dr. Zhang’s most impactful contribution is her 2021 study on perioperative outcomes of intracorporeal versus extracorporeal urinary diversion during RARC, which has garnered 23 citations and established key benchmarks for surgical safety. She further advanced the field by leading a multicenter analysis from the Asian RARC Consortium, comparing long-term outcomes of orthotopic neobladder versus ileal conduit diversion—a study with 12 citations that provides crucial evidence for selecting the optimal method. Her 2022 work, with 6 citations, identified risk factors for perioperative complications, helping to improve patient selection and care. Through these studies, Dr. Zhang has shaped clinical guidelines and demonstrated that RARC can achieve excellent long-term results. Her collaborative leadership within the Asian RARC Consortium underscores her role in generating high-quality, multicenter evidence that directly informs surgical decision-making and enhances patient recovery.